PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 1500 Health Care Index returned 5.5% in the first quarter, ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

Investors will be eagerly watching for the performance of CVS Health in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $1.45, marking a 20.77% fall ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has CVS Health (CVS) been one of those stocks this year? By ...

Why CVS Health (CVS) is a Top Value Stock for the Long-Term June 23, 2025 — 09:40 am EDT Written by Zacks Equity Research for Zacks -> ...

Including the $706 million she disposed of in the first quarter, Safra Catz’s $2.5 billion total makes her the top insider ...

SelectQuote’s undervaluation, rising recurring revenue, and margin gains position it well for FY25 despite recent volatility.

Shares of CVS Health Corp. slipped 4.28% to $66.60 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.47% to 6,227.42 and the Dow ...

CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more on CVS stock here.